As of 2026-04-08, the Relative Valuation of Alpine Immune Sciences Inc (ALPN) is (11.56) USD. This relative valuation is based on P/E multiples. With the latest stock price at 64.97 USD, the upside of Alpine Immune Sciences Inc based on Relative Valuation is -117.8%.
The range of the Relative Valuation is (10.62) - (12.07) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 19.7x - 24.6x | 22.0x |
| Forward P/E multiples | 19.8x - 22.5x | 21.0x |
| Fair Price | (10.62) - (12.07) | (11.56) |
| Upside | -116.3% - -118.6% | -117.8% |
| Date | P/E |